Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SoundHeart is a medical technology company dedicated to transforming the management of Congestive Heart Failure (CHF) through advanced non-invasive monitoring. The company has developed a wearable device that utilizes high-fidelity acoustic sensors and proprietary artificial intelligence algorithms to continuously analyze heart sounds. By specifically detecting the S3 gallop—a clinical indicator of fluid overload and heart failure decompensation—the platform provides early warning signs to clinicians before symptoms become severe. This proactive approach aims to reduce hospital readmissions, optimize medication titration, and improve the overall quality of life for cardiac patients. SoundHeart's solution bridges the gap between hospital-grade diagnostics and home-based remote patient monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sound Heart.